In a filing, Vertex Pharmaceuticals, Inc revealed its Officer Tatsis Ourania acquired Company’s shares for reported $0.11 million on Feb 18 ’25. In the deal valued at $455.06 per share,244 shares were bought.
Then, Biller Jonathan bought 1,657 shares, generating $754,034 in total proceeds.
Before that, Tatsis Ourania sold 310 shares. Vertex Pharmaceuticals, Inc shares valued at $142,547 were divested by the EVP, Chief Reg. & Quality Off. at a price of $459.83 per share. As a result of the transaction, Tatsis Ourania now holds 64,021 shares, worth roughly $29.58 million.
Canaccord Genuity upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Hold from a a Sell in a research note published on February 12, 2025; the price target was increased to $424 from $408. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who increased its forecast for the stock in mid February from “a Sell” to “a Hold”. Wells Fargo also remained covering VRTX and has decreased its forecast on January 30, 2025 with a “an Equal weight” recommendation from previously “an Overweight” rating. H.C. Wainwright maintained its rating on December 20, 2024. It rated VRTX as “a Buy”.
Price Performance Review of VRTX
On Tuesday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 0.68% to $462.11. Over the last five days, the stock has lost -1.67%. Vertex Pharmaceuticals, Inc shares have risen nearly 14.75% since the year began. Nevertheless, the stocks have risen 10.58% over the past one year. While a 52-week high of $519.88 was reached on 02/05/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $439.75, while 200 days put it at $462.94.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 453.45, which if violated will result in even more drops to 444.78. On the upside, there is a resistance level at 469.32. A further resistance level may holdings at 476.52. The Relative Strength Index (RSI) on the 14-day chart is 56.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.68%. Stochastics %K at 47.92% indicates the stock is a holding.
